During the forecast period 2023 to 2033, the Congenital Adrenal Hyperplasia treatment market is expected to grow at a value of 8.1% CAGR, according to Future Market Insights. By the year 2033, the global market for Congenital Adrenal Hyperplasia treatment is expected to rise up to a market valuation of US$ 892 Milli.
Tech Moves: Eliem CEO out amid layoffs; Rokt taps Amazon vet to lead new Seattle office; and more geekwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from geekwire.com Daily Mail and Mail on Sunday newspapers.
Zymeworks (ZYME) Provides Update on Key Strategic Priorities and Outlook for 2023 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
– Dr. Craig Hopkinson, currently EVP of Research & Development and Chief Medical Officer at Alkermes, brings strong global orphan drug development expertise – Dr. Paul Streck, former. | December 6, 2022